Search Results - "Lammers, Eline"

An overview of positive cultures and clinical outcomes in septic patients: a sub-analysis of the Prehospital Antibiotics Against Sepsis (PHANTASi) trial by Nannan Panday, Rishi S, Lammers, Eline M J, Alam, Nadia, Nanayakkara, Prabath W B

“…Sepsis remains one of the most important causes of morbidity and mortality worldwide. In approximately 30-50% of cases of suspected sepsis, no pathogen is…”
Get full text

Cardiovascular screening outcomes in the Dutch survivorship care program for Hodgkin lymphoma survivors by Lammers, Eline M J, Nijdam, Annelies, Zijlstra, Josée M, Janus, Cécile P M, de Weijer, Roel J, Appelman, Yolande, Manintveld, Olivier C, Teske, Arco J, van Leeuwen, Flora E, Aleman, Berthe M P

“…Hodgkin lymphoma (HL) survivors are at increased risk of cardiovascular disease (CVD) due to former lymphoma treatment. In 2013, cardiovascular screening for…”
Get full text

Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design by Lammers, Eline M J, Zijlstra, Josée M, Retèl, Valesca P, Aleman, Berthe M P, van Leeuwen, Flora E, Nijdam, Annelies

“…Hodgkin lymphoma (HL) occurs at young ages, with the highest incidence between 20 and 40 years. While cure rates have improved to 80%-90% over the past…”
Get full text

Author's response to commentary on the PHANTASi trial by Nannan Panday, Rishi S, Lammers, Eline M J, Alam, Nadia, Nanayakkara, Prabath W B

Get full text

P070: Design of the INSIGHT study, evaluation of long‐term follow‐up care for lymphoma survivors in the Netherlands: does survivorship care at the BETER clinics reduce morbidity and mortality from late effects of lymphoma treatment and associated costs? by Nijdam, Annelies, Lammers, Eline M.J., Aleman, Berthe M. P., Zijlstra, Josée. M., Van Leeuwen, Flora E.

Get full text

P071: First results of cardiovascular screening in a survivorship care program for Hodgkin lymphoma survivors in the Netherlands by Lammers, Eline M.J., Nijdam, Annelies, Zijlstra, Josée. M., Janus, Cécile P.M., De Weijer, Roel J., Van Leeuwen, Flora E., Aleman, Berthe M. P.

Get full text

In Vitro Model to Predict Response to Daratumumab Therapy in Relapsed/Refractory Multiple Myeloma by Van Nieuwenhuijzen, Niels, Cuenca, Marta, Abbink, Leonie, Lammers, Eline, Jak, Margot, Peperzak, Victor, Minnema, Monique C.

“…Background Since its approval in 2015, daratumumab has become incorporated in standard-of-care regimens of antimyeloma therapy. However, response to…”
Get full text

CD38 and CD45 expression on plasma cells and response to daratumumab in Multiple Myeloma by Lammers, Eline, Cuenca, Marta, Bloem, Andries, Minnema, Monique, Jak, Margot

Get full text